Senti Biosciences Stock Short Ratio
| SNTI Stock | USD 4.42 0.16 3.76% |
Senti Biosciences fundamentals help investors to digest information that contributes to Senti Biosciences' financial success or failures. It also enables traders to predict the movement of Senti Stock. The fundamental analysis module provides a way to measure Senti Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Senti Biosciences stock.
Senti |
Senti Biosciences Company Short Ratio Analysis
Senti Biosciences' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Senti Biosciences Short Ratio | 3.27 X |
Most of Senti Biosciences' fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Senti Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Senti Biosciences has a Short Ratio of 3.27 times. This is 16.15% lower than that of the Biotechnology sector and 55.87% lower than that of the Health Care industry. The short ratio for all United States stocks is 18.25% higher than that of the company.
Senti Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Senti Biosciences' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Senti Biosciences could also be used in its relative valuation, which is a method of valuing Senti Biosciences by comparing valuation metrics of similar companies.Senti Biosciences is currently under evaluation in short ratio category among its peers.
Senti Fundamentals
| Return On Equity | -1.11 | ||||
| Return On Asset | -0.33 | ||||
| Operating Margin | (180.17) % | ||||
| Current Valuation | 45.58 M | ||||
| Shares Outstanding | 4.59 M | ||||
| Shares Owned By Insiders | 21.00 % | ||||
| Shares Owned By Institutions | 23.32 % | ||||
| Number Of Shares Shorted | 53.05 K | ||||
| Price To Book | 1.33 X | ||||
| Price To Sales | 63.15 X | ||||
| Revenue | 2.56 M | ||||
| Gross Profit | (29.78 M) | ||||
| EBITDA | (61.34 M) | ||||
| Net Income | (71.06 M) | ||||
| Cash And Equivalents | 140.78 M | ||||
| Cash Per Share | 3.24 X | ||||
| Total Debt | 37.67 M | ||||
| Debt To Equity | 0.20 % | ||||
| Current Ratio | 8.09 X | ||||
| Book Value Per Share | 14.64 X | ||||
| Cash Flow From Operations | (52.4 M) | ||||
| Short Ratio | 3.27 X | ||||
| Earnings Per Share | (15.59) X | ||||
| Target Price | 10.0 | ||||
| Number Of Employees | 48 | ||||
| Beta | 2.75 | ||||
| Market Capitalization | 45.89 M | ||||
| Total Asset | 119.48 M | ||||
| Retained Earnings | (244.34 M) | ||||
| Working Capital | 58.53 M | ||||
| Current Asset | 7.4 M | ||||
| Current Liabilities | 1.05 M | ||||
| Net Asset | 119.48 M |
About Senti Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Senti Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Senti Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Senti Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Check out Senti Biosciences Piotroski F Score and Senti Biosciences Altman Z Score analysis. For more detail on how to invest in Senti Stock please use our How to Invest in Senti Biosciences guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Senti Biosciences. If investors know Senti will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Senti Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Senti Biosciences is measured differently than its book value, which is the value of Senti that is recorded on the company's balance sheet. Investors also form their own opinion of Senti Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Senti Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Senti Biosciences' market value can be influenced by many factors that don't directly affect Senti Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Senti Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Senti Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Senti Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.